Skip to main navigation Skip to search Skip to main content

PARP inhibition selectively increases sensitivity to cisplatin in ERCC1-low non-small cell lung cancer cells

Research output: Contribution to journal › Article › peer-review

90   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'PARP inhibition selectively increases sensitivity to cisplatin in ERCC1-low non-small cell lung cancer cells'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology